Susan Landau is Associate Research Scientist in the Helen Wills Neuroscience Institute at the University of California, Berkeley. Her research focuses on understanding the risk factors and pathophysiology that underlie the earliest stages of Alzheimer’s disease, with a particular emphasis on amyloid and tau biomarkers, and implementation of standardized neuroimaging practices across large multisite studies. She is principal investigator of U.S. POINTER Imaging, an ancillary study to the U.S. POINTER Trial that is investigating the effects of lifestyle interventions on Alzheimer’s disease brain biomarkers and cognition in at-risk older adults. She is a PET imaging Core Investigator for the Alzheimer’s Disease Neuroimaging Initiative and the DOD-ADNI study of aging and imaging biomarkers in Vietnam War Veterans.